The defeat of the temporal bone in Paget’s disease as a cause of hearing loss in elderly and senile age
- Authors: Ivanov S.A.1, Zhuravskii S.G.2
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- Pavlov First Saint Petersburg State Medical University
- Issue: Vol 22, No 4 (2018)
- Pages: 25-30
- Section: Articles
- URL: https://journals.rcsi.science/RFD/article/view/11044
- DOI: https://doi.org/10.17816/RFD2018425-30
- ID: 11044
Cite item
Full Text
Abstract
Paget’s disease of bone is a localized disorder of bone remodeling. These functional and structural alterations, interacting with the specific characteristics of the site of involvement, account for most of the complications of the disease. Bilateral progressive hearing loss is the most frequently encountered complication of Paget’s disease, because of the involvement of the temporal bones. There may be difficulty in distinguishing patients with presbycusis from those with Paget’s disease-related hearing loss. Pagetic hearing loss seems to be stabilized by effective medical treatment. For patients with severe hearing loss, cochlear implantation may be recommended.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Sergey A. Ivanov
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: serjivanov84@gmail.com
PhD, Assistant Professor of the Department of Family Medicine
Russian Federation, Saint PetersburgSergey G. Zhuravskii
Pavlov First Saint Petersburg State Medical University
Email: s.jour@mail.ru
DSc, Leading Researcher of Laboratory of Hearing and Speech
Russian Federation, Saint PetersburgReferences
- Paget J. On a Form of Chronic Inflammation of Bones (Osteitis Deformans). Med Chir Trans. 1877;60:37-64.9.
- Bilezikian JP. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 9th ed. Hoboken: Wiley-Blackwell; 2018.
- Рожинская Л.Я. Болезнь Педжета // Остеопороз и остеопатии. - 2007. - Т. 10. - № 2. - С. 29-31. [Rozhinskaya LY. Bolezn’ Pedzheta. Osteoporosis and bone diseases. 2007;10(2):29-31. (In Russ.)] doi: 10.14341/osteo2007229-31.
- Aoki M, Tanahashi S, Mizuta K, Kato H. Treatment for Progressive Hearing Loss Due to Paget’s Disease of Bone - A Case Report and Literature Review. J Int Adv Otol. 2015;11(3):267-270. doi: 10.5152/iao.2015.1572.
- Monsell EM. Emerging concept of hearing loss in Paget’s disease of bone. Clin Rev Bone Miner Metab. 2002;1:145-147.
- Monsell EM. The mechanism of hearing loss in Paget’s disease of bone. Laryngoscope. 2004;114(4):598-606. doi: 10.1097/00005537-200404000-00002.
- Donath J, Krasznai M, Fornet B, et al. Effect of bisphosphonate treatment in patients with Paget’s disease of the skull. Rheumatology (Oxford). 2004;43(1):89-94. doi: 10.1093/rheumatology/keg477.
- Башкова И.Б., Николаев Н.С., Безлюдная Н.В., Кичигин В.А. Диагностические аспекты костной болезни Педжета в клинической практике // Научно-практическая ревматология. - 2017. - Т. 55. - № 6. - С. 690-697. [Bashkova IB, Nikolaev NS, Bezlyudnaya NV, Kichigin VA. Diagnostic aspects of Paget’s disease of bone in clinical practice. Science-practical rheumatology. 2017;55(6):690-697. (In Russ.)] doi: 10.14412/1995-4484-2017-690-697.
- Visconti MR, Usategui-Martin R, Ralston SH. Antibody Response to Paramyxoviruses in Paget’s Disease of Bone. Calcif Tissue Int. 2017;101(2):141-147. doi: 10.1007/s00223-017-0265-4.
- Matthews BG, Afzal MA, Minor PD, et al. Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget’s disease. J Clin Endocrinol Metab. 2008;93(4):1398-1401. doi: 10.1210/jc.2007-1978.
- Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, et al. Frequency and characteristics of familial aggregation of Paget’s disease of bone. J Bone Miner Res. 1995;10(4):663-670. doi: 10.1002/jbmr.5650100421.
- Siris ES, Ottman R, Flaster E, Kelsey JL. Familial aggregation of Paget’s disease of bone. 1991. J Bone Miner Res. 2005;20(3):542-547. doi: 10.1359/jbmr.2005.20.3.541.
- Hocking LJ, Herbert CA, Nicholls RK, et al. Genomewide search in familial Paget’s disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet. 2001;69(5):1055-1061. doi: 10.1086/323798.
- Visconti MR, Langston AL, Alonso N, et al. Mutations of SQSTM1 are associated with severity and clinical outcome in Paget’s disease of bone. J Bone Miner Res. 2010;25(11):2368-2373. doi: 10.1002/jbmr.132.
- Luo H. Selective Autophagy Eats Up Invading Viruses. J Antivir Antiretrovir. 2012;4(3):8-9. doi: 10.4172/jaa.1000e104.
- Zatloukal K, Stumptner C, Fuchsbichler A, et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol. 2002;160(1):255-263. doi: 10.1016/S0002-9440(10)64369-6.
- Jameson JL. Harrison’s Endocrinology. 2nd Edition. New York: McGraw-Hill Press; 2010.
- Singer FR, Mills BG, Gruber HE, et al. Ultrastructure of bone cells in Paget’s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P51-54. doi: 10.1359/jbmr.06s209.
- Nebot Valenzuela E, Pietschmann P. Epidemiology and pathology of Paget’s disease of bone - a review. Wien Med Wochenschr. 2017;167(1-2):2-8. doi: 10.1007/s10354-016-0496-4.
- Amilibia Cabeza E, Holgado Perez S, Perez Grau M, et al. Hearing in Paget’s disease of bone. Acta Otorrinolaringol Esp. 2018. doi: 10.1016/j.otorri.2018.04.002.
- Bone HG. Nonmalignant complications of Paget’s disease. J Bone Miner Res. 2006;21 Suppl 2:P64-68. doi: 10.1359/jbmr.06s212.
- Khetarpal U, Schuknecht HF. In search of pathologic correlates for hearing loss and vertigo in Paget’s disease. A clinical and histopathologic study of 26 temporal bones. Ann Otol Rhinol Laryngol Suppl. 1990;145:1-16. doi: 10.1177/00034894900990S301.
- Kao SY, Kempfle JS, Jensen JB, et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. Neurobiol Dis. 2013;56:25-33. doi: 10.1016/j.nbd.2013.04.008.
- Adams JC. Clinical implications of inflammatory cytokines in the cochlea: a technical note. Otol Neurotol. 2002;23(3):316-322.
- Sousa CS, Castro Júnior ND, Larsson EJ, Ching ТН. Risk factors for presbycusis in a socioeconomic middle-class sample. Braz J Otorhinolaryngol. 2009;75(4):530-536. doi: 10.1590/S1808-86942009000400011.
- Parham K, Lin FR, Coelho DH, et al. Comprehensive management of presbycusis: central and peripheral. Otolaryngol Head Neck Surg. 2013;148(4):537-539. doi: 10.1177/0194599813477596.
- Singer FR, Bone HG, 3rd, Hosking DJ, et al. Paget’s disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(12):4408-4422. doi: 10.1210/jc.2014-2910.
- Murdin L, Yeoh LH. Hearing loss treated with pamidronate. J R Soc Med. 2005;98(6):272-274. doi: 10.1258/jrsm.98.6.272.
- Takano K, Saikawa E, Ogasawara N, Himi T. Cochlear implantation in a patient with Paget’s disease. Am J Otolaryngol. 2014;35(3):408-410. doi: 10.1016/j.amjoto.2014.02.011.
Supplementary files
